Compare FLOC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLOC | CYRX |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 509.0M | 472.7M |
| IPO Year | 2025 | N/A |
| Metric | FLOC | CYRX |
|---|---|---|
| Price | $20.43 | $11.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $30.17 | $12.83 |
| AVG Volume (30 Days) | 222.4K | ★ 348.9K |
| Earning Date | 11-05-2025 | 03-03-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.37 | 1.27 |
| Revenue | ★ $748,499,000.00 | $243,795,000.00 |
| Revenue This Year | $43.28 | N/A |
| Revenue Next Year | $7.88 | $9.27 |
| P/E Ratio | $14.85 | ★ $8.73 |
| Revenue Growth | ★ 76.22 | 41.27 |
| 52 Week Low | $14.03 | $4.58 |
| 52 Week High | $30.50 | $11.44 |
| Indicator | FLOC | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 72.65 | 68.61 |
| Support Level | $19.02 | $10.32 |
| Resistance Level | $20.33 | $10.99 |
| Average True Range (ATR) | 0.66 | 0.44 |
| MACD | 0.09 | 0.11 |
| Stochastic Oscillator | 95.06 | 82.32 |
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.